TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Sveprol Bio Production AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
300
|
514
|
4,716 |
| Financial expenses |
34
|
91
|
156 |
| Earnings before taxes |
-157
|
188
|
9,306 |
| EBITDA |
-37
|
365
|
9,526 |
| Total assets |
2,504
|
3,535
|
8,886 |
| Current assets |
51
|
2,526
|
1,345 |
| Current liabilities |
563
|
298
|
211 |
| Equity capital |
1,736
|
2,827
|
8,068 |
| - share capital |
22
|
23
|
22 |
| Employees (average) |
1
|
3
|
12 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
69.3%
|
80.0%
|
90.8% |
| Turnover per employee |
300
|
171
|
393 |
| Profit as a percentage of turnover |
-52.3%
|
36.6%
|
197.3% |
| Return on assets (ROA) |
-4.9%
|
7.9%
|
106.5% |
| Current ratio |
9.1%
|
847.7%
|
637.4% |
| Return on equity (ROE) |
-9.0%
|
6.7%
|
115.3% |
| Change turnover |
-196
|
-4,216
|
-335 |
| Change turnover % |
-40%
|
-89%
|
-7% |
| Chg. No. of employees |
-2
|
-9
|
-10 |
| Chg. No. of employees % |
-67%
|
-75%
|
-45% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.